Related Experiment Video
Updated: Jun 22, 2026
06:35
Isolation of Cerebral Capillaries from Fresh Human Brain Tissue
Published on: September 12, 2018
Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome
1Faculty of Pharmacy, The University of Sydney, NSW Australia 2006. maryb@pharm.usyd.edu.au
Current Drug Metabolism
|June 13, 2009
Summary
Gender significantly impacts drug response by altering P-glycoprotein activity, a key drug transporter. Understanding these differences is crucial for personalized medicine and optimizing drug therapy.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- Drug disposition and toxicity vary between sexes due to complex physiological and molecular factors.
- Drug transporters and metabolizing enzymes are key regulators of xenobiotic metabolism and elimination.
- P-glycoprotein is a predominant drug transporter implicated in xenobiotic efflux.
Purpose of the Study:
- To review the role of P-glycoprotein in mediating gender differences in drug disposition and response.
- To explore the molecular mechanisms underlying gender-specific transporter expression and function.
- To discuss the impact of gender on drug exposure and therapeutic outcomes.
Main Methods:
- Literature review focusing on P-glycoprotein and gender-related drug disposition.
- Analysis of studies investigating transporter expression and function in different genders.
- Examination of molecular mechanisms influencing transporter activity.
Main Results:
- Gender-specific differences in P-glycoprotein expression and function significantly affect drug concentrations.
- These transporter variations contribute to observed gender disparities in drug response and toxicity.
- Molecular mechanisms underlying these gender differences are multifaceted.
Conclusions:
- P-glycoprotein acts as a critical molecular mediator of gender differences in drug exposure and response.
- Understanding gender-specific transporter roles is essential for optimizing pharmacotherapy.
- Further research into transporter regulation can lead to improved, sex-tailored drug treatments.
Related Concept Videos
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:19Factors Affecting Drug Biotransformation: Biological
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...